John Crean
Impact in
- Ophthalmology top 1%
- Glaucoma and retinal disorders
-
- Spine and Intervertebral Disc Pathology
Papers in
-
- Connective Tissue Growth Factor Research 14
- Renal and related cancers 10
- Epigenetics and DNA Methylation 7
- Co-authors
- Catherine GodsonAbbot F. ClarkColm O’BrienStephen M. EisensteinVictor C. DuanceFinian MartinSally RobertsR.P. Kirwan
- Journals
- The FASEB Journal (5 papers)Diabetes Technology & Therapeutics (3 papers)Investigative Ophthalmology & Visual Science (3 papers)Journal of Biological Chemistry (2 papers)Diabetes Care (2 papers)
- Partner nations
- IrelandUnited KingdomUnited States
In The Last Decade
John Crean
55 papers receiving 2.0k citations
Peers
Comparison fields: 5 of 121
- Ophthalmology 383
- Pathology and Forensic Medicine 389
- Endocrinology, Diabetes and Metabolism 286
- Nephrology 118
- Pharmacology 244
Countries citing papers authored by John Crean
This map shows the geographic impact of John Crean's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Crean with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Crean more than expected).
Fields of papers citing papers by John Crean
This network shows the impact of papers produced by John Crean. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Crean. The network helps show where John Crean may publish in the future.
Co-authors
The 25 scholars most cited alongside John Crean, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 8 | |
| 2 | 2025 | 2 | |
| 3 | 2022 | 32 | |
| 4 | 2022 | 16 | |
| 5 | 2022 | 10 | |
| 6 | 2017 | 3 | |
| 7 | Connective Tissue Growth Factor Induction of Lysl Oxidase (LOX) Enzyme Expression in Human Trabecular Meshwork Cells is reduced by FG-3019 | 2013 | 1 |
| 8 | 2013 | 13 | |
| 9 | 2013 | 30 | |
| 10 | 2011 | 8 | |
| 11 | 2011 | 11 | |
| 12 | 2010 | 55 | |
| 13 | 2009 | 37 | |
| 14 | 2007 | 31 | |
| 15 | 2006 | 57 | |
| 16 | 2006 | 77 | |
| 17 | 2004 | 86 | |
| 18 | 2002 | 135 | |
| 19 | 1998 | 113 | |
| 20 | 1997 | 177 |
About John Crean
John Crean is a scholar working on Nephrology, Molecular Biology, Ophthalmology, Pathology and Forensic Medicine and Endocrinology, Diabetes and Metabolism, having authored 55 papers that have together received 2.0k indexed citations. Recurring topics across this work include Connective Tissue Growth Factor Research (14 papers), Renal and related cancers (10 papers), Epigenetics and DNA Methylation (7 papers), Diabetes Management and Research (6 papers), Diabetes Treatment and Management (6 papers), Tissue Engineering and Regenerative Medicine (5 papers), Glaucoma and retinal disorders (5 papers) and Systemic Sclerosis and Related Diseases (5 papers). The work is most often cited by research in Ophthalmology (383 citations), Pathology and Forensic Medicine (389 citations), Endocrinology, Diabetes and Metabolism (286 citations), Nephrology (118 citations) and Pharmacology (244 citations). John Crean has collaborated with scholars based in Ireland, United Kingdom and United States. Frequent co-authors include Catherine Godson, Abbot F. Clark, Colm O’Brien, Stephen M. Eisenstein, Victor C. Duance, Finian Martin, Sally Roberts, R.P. Kirwan, Hugh R. Brady and Cecilia Fenerty. Their work appears in journals such as The FASEB Journal, Diabetes Technology & Therapeutics, Investigative Ophthalmology & Visual Science, Journal of Biological Chemistry and Diabetes Care.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.